These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 16333069
41. Specific antibody responses to West Nile virus infections in horses preimmunized with inactivated Japanese encephalitis vaccine: evaluation of blocking enzyme-linked immunosorbent assay and complement-dependent cytotoxicity assay. Kitai Y, Shirafuji H, Kanehira K, Kamio T, Kondo T, Konishi E. Vector Borne Zoonotic Dis; 2011 Aug; 11(8):1093-8. PubMed ID: 21254919 [Abstract] [Full Text] [Related]
42. Comparison of assays for the detection of West Nile virus antibodies in equine serum after natural infection or vaccination. Joó K, Bakonyi T, Szenci O, Sárdi S, Ferenczi E, Barna M, Malik P, Hubalek Z, Fehér O, Kutasi O. Vet Immunol Immunopathol; 2017 Jan; 183():1-6. PubMed ID: 28063471 [Abstract] [Full Text] [Related]
43. Cloning and expression of an envelope gene of West Nile virus and evaluation of the protein for use in an IgM ELISA. Saxena D, Parida M, Rao PV, Kumar JS. Diagn Microbiol Infect Dis; 2013 Apr; 75(4):396-401. PubMed ID: 23357292 [Abstract] [Full Text] [Related]
44. West Nile encephalitis outbreak in Kerala, India, 2011. Anukumar B, Sapkal GN, Tandale BV, Balasubramanian R, Gangale D. J Clin Virol; 2014 Sep; 61(1):152-5. PubMed ID: 24985196 [Abstract] [Full Text] [Related]
45. Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections. Tsai WY, Driesse K, Tsai JJ, Hsieh SC, Sznajder Granat R, Jenkins O, Chang GJ, Wang WK. Emerg Microbes Infect; 2020 Dec; 9(1):1722-1732. PubMed ID: 32684139 [Abstract] [Full Text] [Related]
46. Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid. Muerhoff AS, Dawson GJ, Dille B, Gutierrez R, Leary TP, Gupta MC, Kyrk CR, Kapoor H, Clark P, Schochetman G, Desai SM. Clin Diagn Lab Immunol; 2004 Jul; 11(4):651-7. PubMed ID: 15242936 [Abstract] [Full Text] [Related]
47. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. Litzba N, Schuffenecker I, Zeller H, Drosten C, Emmerich P, Charrel R, Kreher P, Niedrig M. J Virol Methods; 2008 Apr; 149(1):175-9. PubMed ID: 18294706 [Abstract] [Full Text] [Related]
48. A new competitive ELISA detects West Nile virus infection using monoclonal antibodies against the precursor-membrane protein of West Nile virus. Hirota J, Shimizu S. J Virol Methods; 2013 Mar; 188(1-2):132-8. PubMed ID: 23266257 [Abstract] [Full Text] [Related]
49. Seroprevalence of West Nile virus in Iran. Chinikar S, Shah-Hosseini N, Mostafavi E, Moradi M, Khakifirouz S, Jalali T, Goya MM, Shirzadi MR, Zainali M, Fooks AR. Vector Borne Zoonotic Dis; 2013 Aug; 13(8):586-9. PubMed ID: 23697768 [Abstract] [Full Text] [Related]
50. Human cases of West Nile Virus infection in north-eastern Italy, 15 June to 15 November 2010. Barzon L, Pacenti M, Cusinato R, Cattai M, Franchin E, Pagni S, Martello T, Bressan S, Squarzon L, Cattelan A, Pellizzer G, Scotton P, Beltrame A, Gobbi F, Bisoffi Z, Russo F, Palu G. Euro Surveill; 2011 Aug 18; 16(33):. PubMed ID: 21871228 [Abstract] [Full Text] [Related]
51. Comparative evaluation of chemiluminescent immunoassay and enzyme-linked immunosorbent assays for the diagnosis of West Nile virus infections. Gómez-Vicente E, Garcia R, Calatrava E, Olivares Duran MJ, Gutiérrez-Bautista JF, Rodriguez-Granger J, Cobo F, Navarro Mari JM, Sampedro-Martinez A. APMIS; 2022 Apr 18; 130(4):215-220. PubMed ID: 35060204 [Abstract] [Full Text] [Related]
52. Persistence of anti-West Nile virus-specific antibodies among asymptomatic blood donors in northeastern Italy. Pierro A, Gaibani P, Manisera C, Rossini G, Finarelli AC, Ghinelli F, Macini P, Landini MP, Sambri V. Vector Borne Zoonotic Dis; 2013 Dec 18; 13(12):892-3. PubMed ID: 23919606 [Abstract] [Full Text] [Related]
53. Serological Evidence of Tick-Borne Encephalitis and West Nile Virus Infections Among Children with Arthritis in Turkey. Yilmaz H, Barut K, Karakullukcu A, Kasapcopur O, Kocazeybek B, Altan E, Cizmecigil UY, Yilmaz A, Bilgin Z, Ulutas Esatgil M, Klaus C, Richt JA, Turan N. Vector Borne Zoonotic Dis; 2019 Jun 18; 19(6):446-449. PubMed ID: 30688547 [Abstract] [Full Text] [Related]
54. A study of West Nile virus infection in Iranian blood donors. Sharifi Z, Mahmoodian Shooshtari M, Talebian A. Arch Iran Med; 2010 Jan 18; 13(1):1-4. PubMed ID: 20039761 [Abstract] [Full Text] [Related]
55. T7 phage display of Ep15 peptide for the detection of WNV IgG. Herrmann S, Leshem B, Lobel L, Bin H, Mendelson E, Ben-Nathan D, Dussart P, Porgador A, Rager-Zisman B, Marks RS. J Virol Methods; 2007 May 18; 141(2):133-40. PubMed ID: 17215048 [Abstract] [Full Text] [Related]
56. [Investigation of West Nile virus seroprevalence in healthy blood donors]. Hızel K, Yenicesu I, Erdal B, Yeşilyurt E, Fidan I, Kalkancı A, Dilsiz G. Mikrobiyol Bul; 2010 Jul 18; 44(3):425-30. PubMed ID: 21063992 [Abstract] [Full Text] [Related]
57. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine. Kitai Y, Kondo T, Konishi E. J Virol Methods; 2011 Jan 18; 171(1):123-8. PubMed ID: 20974180 [Abstract] [Full Text] [Related]
58. West Nile seroprevalence study in Bolivian horses, 2011. Mazzei M, Savini G, Di Gennaro A, Macchioni F, Prati MC, Guzmàn LR, Tolari F. Vector Borne Zoonotic Dis; 2013 Dec 18; 13(12):894-6. PubMed ID: 24107210 [Abstract] [Full Text] [Related]
59. Detection of anti-West Nile virus immunoglobulin M in chicken serum by an enzyme-linked immunosorbent assay. Johnson AJ, Langevin S, Wolff KL, Komar N. J Clin Microbiol; 2003 May 18; 41(5):2002-7. PubMed ID: 12734241 [Abstract] [Full Text] [Related]
60. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels. Prince HE, Leber AL. Clin Diagn Lab Immunol; 2002 Jul 18; 9(4):824-7. PubMed ID: 12093680 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]